Therapeutic Asset Ratings
7,018 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pembrolizumab
Urothelial Carcinoma
Sutro Biopharma, Inc.
P3
BB
(70)
Penpulimab
Hepatocellular Carcinoma
West China Hospital
P3
BB
(70)
Pevonedistat
Chronic Myelomonocytic Leukemia
Takeda
P3
BB
(70)
PREDNISONE TABLETS
Prostate Adenocarcinoma
Mayo Clinic
P3
BB
(70)
PREDNISONE TABLETS
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)
P3
BB
(70)
PREDNISONE TABLETS
Acute Myeloid Leukemia
Children's Oncology Group
P3
BB
(70)
PREDNISONE TABLETS
Myeloid Malignancies
Prelude Therapeutics
P3
BB
(70)
PREDNISONE TABLETS
Recurrent Childhood Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(70)
Pyrotinib
Breast Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
BB
(70)
qls32015
Plasma Cell Myeloma
Qilu Pharmaceutical Co., Ltd.
P3
BB
(70)
Recombinant Nonavalent Human Papillomavirus Vaccine
Human Papilloma Virus Infection
Beijing Health Guard Biotechnology, Inc
P3
BB
(70)
Regorafenib
Regorafenib
M.D. Anderson Cancer Center
P3
BB
(70)
Rgx-121
Mucopolysaccharidosis Type 2
REGENXBIO Inc.
P3
BB
(70)
Rivoceranib
Apatinib
The First Affiliated Hospital of Xiamen University
P3
BB
(70)
Romidepsin
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer Center
P3
BB
(70)
Romidepsin
Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Fred Hutchinson Cancer Center
P3
BB
(70)
Romidepsin
Angioimmunoblastic T-Cell Lymphoma
The Lymphoma Academic Research Organisation
P3
BB
(70)
Romidepsin
Childhood Acute Myeloid Leukemia
Washington University School of Medicine
P3
BB
(70)
Romiplostim
Thrombocytopenia
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(70)
Sargramostim
Uveal Melanoma
Thomas Jefferson University
P3
BB
(70)
Semaglutide
Appetite Regulation
Mount Sinai Hospital, Canada
P3
BB
(70)
Serplulimab
Immunotherapy
Tao Zhang
P3
BB
(70)
Serplulimab
Non-Small Cell Squamous Lung Carcinoma
Shanghai Henlius Biotech
P3
BB
(70)
Shr-8068
Advanced Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
P3
BB
(70)
Sigvotatug Vedotin
Non-Small Cell Lung Carcinoma
Pfizer
P3
BB
(70)
Showing 576 to 600 of 7,018 assets
Previous
Page 24 of 281
Next